Global Protein Therapeutics Market (2020 to 2025) – by Component, Therapy Area, Function & Region – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Protein Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025” report has been added to ResearchAndMarkets.com’s offering.

The global protein therapeutics market grew at a CAGR of around 7% during 2014-2019. Looking forward, the publisher expects the global protein therapeutics market to continue its moderate growth during the next five years.

Protein therapeutics refers to artificially synthesized protein-based medicines. They are fast-acting, potent medicines that deliver small protein molecules to the body in a specific amount. They usually consist of recombinant forms of naturally occurring proteins, such as monoclonal antibodies, insulin, fusion proteins, erythropoietin, interferon, human growth hormones (HGH) and follicle-stimulating hormones. They aid in treating chronic medical ailments, such as cancer, diabetes, neurodegenerative disorders and immunological, hematological, hormonal and genetic disorders. Various combination therapy drugs are also used with protein therapeutics that can be inhaled, injected or orally administered.

The increasing prevalence of chronic medical ailments is one of the key factors driving the growth of the market. In line with this, the rising awareness among the masses regarding the benefits of protein therapeutics, such as minimal risks of side effects and high efficiency, are contributing to the market growth. Monoclonal antibodies are being widely researched and used for the treatment of various viral and bacterial diseases and pharmaceutical companies are using protein therapeutics for drug discovery and development. The sudden outbreak of the coronavirus disease (COVID-19) is further providing growth opportunities to market players. For instance, Molecular Partners AG, a Switzerland-based clinical stage biotechnology company, is developing a new class of protein therapeutics, called DARPin, to inhibit the proliferation of the virus.

Additionally, the development of novel recombinant proteins, peptides, antibody-based drugs and plasma proteins is acting as other-growth inducing factors. These protein therapeutics are extensively used in replacement therapies to treat genetic and autoimmune disorders, such as dysfibrinogenemia, afibrinogenemia, and hypofibrinogenemia. (Read more…) Other factors, including extensive research and development (R&D) activities in the field of protein engineering, along with significant improvements in the healthcare infrastructure, are expected to drive the market further.

Key Questions Answered in This Report:

• How has the global protein therapeutics market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the global protein therapeutics market?
• What are the key regional markets?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the therapy area?
• What is the breakup of the market based on the function?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the global protein therapeutics market and who are the key players?
• What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.3.1 Primary Sources

2.3.2 Secondary Sources

2.4 Market Estimation

2.4.1 Bottom-Up Approach

2.4.2 Top-Down Approach

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Protein Therapeutics Market

5.1 Market Overview

5.2 Market Performance

5.3 Impact of COVID-19

5.4 Market Forecast

6 Market Breakup by Component

6.1 Monoclonal Antibodies (mAbs)

6.1.1 Market Trends

6.1.2 Market Forecast

6.2 Human Insulin

6.2.1 Market Trends

6.2.2 Market Forecast

6.3 Erythropoietin

6.3.1 Market Trends

6.3.2 Market Forecast

6.4 Clotting Factors

6.4.1 Market Trends

6.4.2 Market Forecast

6.5 Fusion Protein

6.5.1 Market Trends

6.5.2 Market Forecast

6.6 Others

6.6.1 Market Trends

6.6.2 Market Forecast

7 Market Breakup by Therapy Area

7.1 Metabolic Disorders

7.1.1 Market Trends

7.1.2 Market Forecast

7.2 Immunological Disorders

7.2.1 Market Trends

7.2.2 Market Forecast

7.3 Hematological Disorders

7.3.1 Market Trends

7.3.2 Market Forecast

7.4 Cancer

7.4.1 Market Trends

7.4.2 Market Forecast

7.5 Hormonal Disorders

7.5.1 Market Trends

7.5.2 Market Forecast

7.6 Genetic Disorders

7.6.1 Market Trends

7.6.2 Market Forecast

7.7 Others

7.7.1 Market Trends

7.7.2 Market Forecast

8 Market Breakup by Function

8.1 Enzymatic and Regulatory Activity

8.1.1 Market Trends

8.1.2 Market Forecast

8.2 Special Targeting Activity

8.2.1 Market Trends

8.2.2 Market Forecast

8.3 Vaccines

8.3.1 Market Trends

8.3.2 Market Forecast

8.4 Protein Diagnostics

8.4.1 Market Trends

8.4.2 Market Forecast

9 Market Breakup by Region

9.1 North America

9.2 Asia Pacific

9.3 Europe

9.4 Latin America

9.5 Middle East and Africa

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure

14.2 Key Players

14.3 Profiles of Key Players

Companies Mentioned

• Amgen Inc.
• Abbott Laboratories
• Abbvie Inc.
• Baxter International Inc.
• Biogen Inc.
• Csl Behring L.L.C. (CSL Limited)
• Eli Lilly and Company
• F. Hoffmann-La Roche AG (Roche Holding AG)
• Johnson & Johnson
• Merck & Co. Inc.
• Novo Nordisk A/S (Novo Holdings A/S) and Pfizer Inc.

For more information about this report visit https://www.researchandmarkets.com/r/pi68kz

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900